{"id":"cdec61a2-0b14-4d4f-a9a6-34bff507c286","name":"Medical Microinstruments (MMI)","slug":"medical-microinstruments","description":"Medical Microinstruments (MMI) is an Italian medical device company developing the Symani Surgical System, a robotic microsurgery platform that enables surgeons to perform complex microsurgical procedures with enhanced precision. Symani received FDA De Novo authorization in April 2024 and CE mark certification, with the first U.S. clinical use completed in 2025. MMI raised $110M in venture capital to support commercial rollout, with the system manufactured in Pisa, Italy.","status":"active","founded":null,"hq":"Pisa, Italy","hqLat":43.4714722,"hqLng":10.6797912,"hqGeocodedAt":"2026-08-05T14:38:49.818Z","hqAddress":null,"hqPrecision":null,"website":null,"fundingTotal":"75000000","type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.mmimicro.com/","title":"Medical Microinstruments Symani","date_accessed":"2026-06-24"}],"keyFacts":[{"label":"Robot","value":"Symani Surgical System for microsurgery"},{"label":"Focus","value":"Reconstructive and soft-tissue microsurgical procedures"},{"label":"Technology","value":"Wristed microinstruments with tremor filtration and motion scaling"},{"label":"Scale","value":"Enables reconnection of blood vessels and lymphatic ducts as small as ~0.1 mm"},{"label":"CEO","value":"Mark Toland (former CEO of Corindus, acquired by Siemens for $1.1B)"},{"label":"FDA authorization","value":"De Novo (April 2024)"},{"label":"Total funding","value":"$110M+ ($75M Series B)"},{"label":"Product","value":"Symani Surgical System (robotic microsurgery)"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-24T08:14:44.819Z","updatedAt":"2026-08-05T14:38:49.820Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/medical-microinstruments","url":"https://registry.deploy.report/companies/medical-microinstruments","name":"Medical Microinstruments (MMI)","description":"Medical Microinstruments (MMI) is an Italian medical device company developing the Symani Surgical System, a robotic microsurgery platform that enables surgeons to perform complex microsurgical procedures with enhanced precision. Symani received FDA De Novo authorization in April 2024 and CE mark certification, with the first U.S. clinical use completed in 2025. MMI raised $110M in venture capital to support commercial rollout, with the system manufactured in Pisa, Italy.","identifier":"cdec61a2-0b14-4d4f-a9a6-34bff507c286","address":"Pisa, Italy","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}